It truly is pathetic! The morning the L blinded data manuscript came out in the Journal of Translation Medicine, it was posted on here before a PR ever came out. I called LG right away to ask why the Co hadn't PR'd the "critical mass" "top tier" manuscript we had ALL been waiting for for months. He said, "we did PR it." I then had to inform him that in fact no PR from the Co had come out. He told me to call him back in a couple minutes which I did for him then to tell me it would be PR'd soon and that they had a "clitch" with their PR dept in getting it out.
I understand being spread thin and undermanned but for God sakes, when our Co IR person (LG) has been talking about "critical mass" "inflection point" yada yada yada for months on end regarding this manuscript, you'd think they would have had a well executed plan in place months ahead.
It's laughable, sad and tragic and unfortunately at the expense of shareholders, patients and the medical community who have been following this trial. Their execution has been amateurish at best!
Hoping data can save us from this absolutely pathetic management team!
News 
Market Data 
Discover 
AI
